Cultivan

Elanco Animal Health Inc (NYSE: ELAN) announced Friday that it has struck a deal to buy pet therapeutics company Aratana Therapeutics Inc (NASDAQ: PETX). The two companies are partners on the canine drug Galliprant. What Happened The stock-for-stock deal is worth as much as $245...